Leap Therapeutics, Inc.
(NASDAQ:LPTX)
$0.641
-0.03 (-4.33%)
At Close: 4:00 PM
$0.704
0.03 (5.05%)
Pre Market: 4:15 AM
Leap Therapeutics, Inc.
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
LPTX Stock Price Today
Leap Therapeutics, Inc. (LPTX) stock declined over -4.33% intraday to trade at $0.6407 a share on NASDAQ. The stock opened with a gain of 4.52% at $0.7 and touched an intraday high of $0.71, falling -4.33% against the last close of $0.67. The Leap Therapeutics, Inc. in stock market went to a low of $0.63 during the session.
Stock Snapshot
$0.67
Prev. Close
66.27 Million
Market Cap
$0.63
Day Low
$0.7
Open
113.24 Million
Number of Shares
$0.71
Day High
-
P/E ratio
-0.57
EPS (TTM)
0.92
Cash Flow per Share
5.34
Free Float in %
0.78
Book Value
338,865
Volume
Contact Details
47 Thorndike Street
Suite B1-1
Cambridge, MA 02141
United States
Website:https://www.leaptx.com
Contact #:617 714 0360
Company Information
Employees36
Beta0.69
Sales or Revenue$750 Thousands
5Y Sales Change-
Fiscal Year EndsDec. 2021
SectorHealth Care
IndustryBiotechnology
About Company
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.
Frequently Asked Questions
What is the current Leap Therapeutics, Inc. (LPTX) stock price?
Leap Therapeutics, Inc. (NASDAQ: LPTX) stock price is $0.64 in the last trading session. During the trading session, LPTX stock reached the peak price of $0.71 while $0.63 was the lowest point it dropped to. The percentage change in LPTX stock occurred in the recent session was -4.33% while the dollar amount for the price change in LPTX stock was -$0.03.
LPTX's industry and sector of operation?
The NASDAQ listed LPTX is part of Biotechnology industry that operates in the broader Health Care sector. Leap Therapeutics, Inc. , a biopharmaceutical company, acquires and develops therapies for the treatment of cancer.
Who are the executives of LPTX?
Mr. Douglas E. Onsi J.D.
CFO, Gen. Counsel, Treasurer & Sec., Pres, CEO & Director
Mr. Augustine J. Lawlor
Chief Operating Officer
Dr. Cynthia A. Sirard
Chief Medical Officer
Mr. Mark O'Mahony
Chief Manufacturing Officer
How LPTX did perform over past 52-week?
LPTX's closing price is 0.60% higher than its 52-week low of $0.4 where as its distance from 52-week high of $2.57 is -0.75%.
How many employees does LPTX have?
Number of LPTX employees currently stands at 36. LPTX operates from 47 Thorndike Street, Suite B1-1, Cambridge, MA 02141, United States.
Link for LPTX official website?
Official Website of LPTX is: https://www.leaptx.com
How do I contact LPTX?
LPTX could be contacted at phone #617 714 0360 and can also be accessed through its website. LPTX operates from 47 Thorndike Street, Suite B1-1, Cambridge, MA 02141, United States.
How many shares of LPTX are traded daily?
LPTX stock volume for the day was 338,865 shares. The average number of LPTX shares traded daily for last 3 months was 820.99 Thousands.
What is the market cap of LPTX currently?
The market value of LPTX currently stands at $66.27 Million with its latest stock price at $0.64 and 113.24 Million of its shares outstanding.